ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Reprogramming the Tumor Immune Microenvironment with ICAM-1-Targeted Antibody‒Drug Conjugates and B7-H3-CD3 Bispecific Antibodies.

Shoubing Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.